Fig. 1From: Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitorsBRAFV600E+ melanoma cell lines display different expression patterns of TNFR1, TNFR2 and CD271. Seven human BRAFV600E+ melanoma cell lines were evaluated for TNFR1, TNFR2 and CD271 expression levels by flow cytometry. Cells were stained by two-step staining.  Dotted line–IgG control. Gray histogram–TNF receptor staining. BRAF mutation status was determined by PCR and flow cytometryBack to article page